Small Study Tests Colchicine for Moderate-to-Severe COVID-19
Authors call for larger clinical trials to further evaluate the efficacy and safety of colchicine as an adjunctive therapy for COVID-19
AAO-HNS Issues Guidance for Bell’s Palsy Treatment During COVID-19
Corticosteroid therapy and/or antiherpes viral therapy recommended for patients developing Bell's palsy after vaccination
Physician’s Briefing Weekly Coronavirus Roundup
Companies Developing Vaccines Against New Coronavirus Variants
GlaxoSmithKline and CureVac to create vaccines that use messenger RNA to combat the virus
COVID-19 Outcomes Worse for Persons Living With Diagnosed HIV
COVID-19 diagnosis rates are similar for those with, without HIV, but hospitalization and death rates are up with HIV
Racial Disparities Seen in Excess Mortality Early in Pandemic
Adjusted excess all-cause mortality was 6.8 per 10,000 for Blacks and 1.5 per 10,000 for Whites, with considerable variation across states
Predictors ID’d for Progression of Mono to Chronic Fatigue
More physical symptoms, immune irregularities seen at baseline in college students who develop postmononucleosis chronic fatigue syndrome
First Federal COVID-19 Vaccination Sites to Open in California
One center will be housed in the Oakland Coliseum, another on the campus of California State University, Los Angeles
Oncology Clinical Trials Decline During Pandemic
Decline in trial launches could have long-term negative impact, authors say
High Efficacy Reported for Sputnik V COVID-19 Vaccine
Interim analysis of data from phase 3 trial shows 91.6 percent efficacy at 21 days after the first dose of the vaccine
